drugset / Trial / NCT05760534
Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to compare ideal body weight- and total body weight-based dosage for remimazolam sedation of obese patients undergoing knee or hip arthroplasty under spinal anesthesia.
Timeline
- Start
- 2023-03-06
- Primary completion
- 2025-11-25
- Completion
- 2025-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remimazolam | Small molecule | 0.2 mg/kg | — |
| Subject | Remimazolam | Small molecule | 1 mg/kg | — |